- AbbVie (NYSE:ABBV) CEO Richard Gonzalez has been holding discreet meetings with Shire (NASDAQ:SHPG) shareholders in London this week, in another pursuit for a $46B takeover, Reuters reports.
- AbbVie is looking to buy Shire mainly as a tax inversion, but to also diversify its drug portfolio.
- The company made no mention of increasing its current bid, but under British takeover rules, it has until July 18 to make another offer or walk away.
- SHPG -0.5% premarket